September 24, 2018
The federal government is deciding what to do on national pharmacare, but any choice will mean interacting with a landscape of existing provincial programs. What intergovernmental challenges does it face and how can it overcome them? Join two expert panels in Toronto and Ottawa to discuss this issue.
Space is limited. To register, please RSVP by Monday, September 24.
We encourage you to share the invitation with interested colleagues. If you have any questions, please do not hesitate to contact us at events@mowatcentre.ca.
Toronto
Tuesday, September 25
8:00-10:00am
The Observatory
Munk School of Global Affairs & Public Policy
University of Toronto
315 Bloor St. West
Toronto, ON
Panelists
Sean Speer
Munk School of Global Affairs & Public Policy
Helen Stevenson
Reformulary Group
Dr. Danielle Martin
Women’s College Hospital and Institute of Health Policy, Management & Evaluation
Erich Hartmann
Mowat Centre
Ottawa
Wednesday, September 26
8:00-10:00am
Tudor Room, 1st Floor
Fairmont Château Laurier
1 Rideau Street
Ottawa, ON
Panelists
Jennifer Wallner
University of Ottawa
Patrick Fafard
University of Ottawa
Erich Hartmann
Mowat Centre
Related Reading
Prescribing Federalism
The intergovernmental implications of a national pharmacare program
The federal government is currently choosing its approach on national pharmacare. New Mowat research finds that the success of any approach depends in part on how it interacts with the variety of existing provincial pharmacare programs.
More
National pharmacare has to overcome intergovernmental hurdles. Can it?
How much Canadians pay for prescription drugs depends very much on where they live. Middle-income residents of Prince Edward Island facing an expensive drug treatment has to cover the first $4,400 with their own money – then their provincial pharmacare program pays for the rest.
More
Prescribing Federalism
The intergovernmental implications of a national pharmacare program
The federal government is currently choosing its approach on national pharmacare. New Mowat research finds that the success of any approach depends in part on how it interacts with the variety of existing provincial pharmacare programs.
More
National pharmacare has to overcome intergovernmental hurdles. Can it?
How much Canadians pay for prescription drugs depends very much on where they live. Middle-income residents of Prince Edward Island facing an expensive drug treatment has to cover the first $4,400 with their own money – then their provincial pharmacare program pays for the rest.
More
This event presented with McKesson Canada.
